Indicatie voor ablatie bij voorkamerfibrillatie Andrea Sarkozy - - PowerPoint PPT Presentation

▶

Nov 03, 2022 22 likes •316 views

Indicatie voor ablatie bij voorkamerfibrillatie Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen Definition and Classification of AF - Practical aspects | Classification of AF | Paroxysmal, persistent, long-standing

SLIDE 1

Andrea Sarkozy Cardiologie Universitair Ziekenhuis Antwerpen

Indicatie voor ablatie bij voorkamerfibrillatie

SLIDE 2

Definition and Classification of AF - Practical aspects | Classification of AF

| Paroxysmal, persistent, long-standing persistent, permanent | Electrical CV ≤ 48 hours or < 7 days = paroxysmal AF

Calkins H: Europace. 2012;14:528, January C: JACC 2104

SLIDE 3

Klinische presentatie van VKF

Nattel S: Eur Heart J 2014;35:1448–1456

SLIDE 4

Natural history of AF - progression

De Sisti PACE 2013;37:345, 2 De Vos JACC 2010;55:725-31 | Yearly progression from paroxysmal/persistent to permanent AF: 3.7%-15% | Age, persistent AF, LA size | Heart failure, Age, TIA/Stroke, COPD , HTN, (HATCH) 2 | sleep apnea, obesitas

SLIDE 5

AF geinduceerde elektrische en strukturele remodelling
Onderliggende CV ziekte veroorzaakt substraat remodelling
Veroudering geassocieerde substraat

Vroegtijdig interventie concept

Nattel S: Eur Heart J 2014;35:1448–1456

SLIDE 6

Pulmonary vein isolation with catheter ablation

SLIDE 7

Interventional EP laboratory

SLIDE 8

Atrial Fibrillation: Catheter ablation of PV focus

SLIDE 9

TEE and fluoroscopy guided transseptal puncture

SLIDE 10

3D electroanatomical mapping

| Placement of a circular mapping catheter (LASSO) and irrigated tip ablation catheter in the LA

SLIDE 11

Circumferentiel Pulmonary vein siolation with RF ablation

SLIDE 12

Indications for catheter ablation in AF

Good indications
Alternative drug therapy: failed / contraindicated / side effects
Benefit: High and long term decrease in AF recurrence - efficacy
Risk: as few as possible complications

SLIDE 13

Efficacy

SLIDE 14

Meta analysis of ablation efficacy

| Paroxysmal AF | 1 y single procedure success: 69 % | 5 y single procedure success: 62%, multiple procedure: 79% | Persistent AF | 1 y single procedure success: 52 % | 3 y single procedure success: 42%, multiple procedures:77% Ganesan JAMA 2013;2:4549

SLIDE 15

Efficacy of persistent, long-standing persistent atrial fibrillation ablation Star AF study

Verma New Eng J Med 2015 | Multicenter randomized trial of 589 pts in 12 countries with persistent AF | Single procedure success at 18 months off AAD for PVI alone: 48% | Two procedures + AAD for PVI alone: 72%

SLIDE 16

Efficacy as compared to antiarrhythmic drugs

Khan Circulation AEP 2014;7:853

SLIDE 17

Earlier ablation is associated with improved outcome

Bunch TJ et al: Heart Rhythm 2013;10:1257 | 4535 paroxysmal-persistent AF pts w ablation 1m to > 5y after first diagnosis | 1 year AF recurrence, death, HF hospitalization highest in most delayed group

SLIDE 18

Early ablation in patients without structural heart diseases might slow AF progression

| 899 pts w median follow up 64 months, AF progression: 6.4% | Progression persistent:10%, long-standing persistent:14,6%, paroxysmal: 2,7% | Progression w comorbidities/cardiomyopathies: 29.9% vs “lone” AF: 9.1% Scaglione Heart Rhythm 2104

SLIDE 19

Very long-term efficacy of catheter ablation

Steinberg JS Heart Rhythm 2104 | 445 pts – free of AF 1 y postablation followed for additional 66 months | At 5 years 16,3% and 10 years 29,8% recurrence | Persistent AF and hypertension are independent risk factors

SLIDE 20

Decreased Stroke rate following ablation

| AF ablation patients have a significantly lower risk of stroke compared to AF patients who do not undergo ablation independent of baseline stroke risk score and age | However, currently following AF ablation anticoagulation is based on CHADS-VASC score irrespective of the result of the ablation Bunch J Heart Rhythm 2013;10:1272

SLIDE 21

Efficacy of atrial fibrillation ablation in paroxysmal AF Smart AF Trial using CF sensing catheter

Natale JACC 2014;64:647-56 | Prospective, multicenter, nonrandomized trial of 171 pts with PAF at 21 sites | Single-procedure 12 m success off AAD therapy: 72%, with CF in operator targeted range: 81%

SLIDE 22

Safety

SLIDE 23

AF ablation USA database: 93801 ablation 2000-2010

Deshmukh Circulation 2013;128:2104

SLIDE 24

Calkins Circulation Arrhythmia 2009;2:349

Safety of catheter ablation therapy as compared to drugs

SLIDE 25

Update on Indications of catheter ablation

SLIDE 26

2012 ESC AF Guideline update, 2012 HRS/EHRA/ECAS Expert Consensus Statement on AF Ablation, 2014 AHA/ACC/HRS AF guideline

Camm AJ Eur Heart J. 2012;33:2719

SLIDE 27

Practical aspects | Personalized informed consent over efficacy and complications of the ablation procedure

SLIDE 28

Conclusions | Paroxysmal, Persistent, and Permanent AF classification should be used | Progression rate from paroxysmal to permanent AF is yearly 5%

| Age, persistent AF, HTN, left atrial dilatation and structural heart and pulmonary disease are predictors

| Early interventions might slow progression

| Delay in AF ablation is associated with worse outcome

SLIDE 29

Conclusions

| Catheter ablation is recommended (class I) in symptomatic paroxysmal AF following failure of one AAD (before amiodarone) | As first line therapy (class IIa) - in case AAD drugs are contraindicated | Personalized informed consent: | Single procedural 12 months success: 70% - 80%, 5y multiple procedures 80% - 85% | Major complications: 4-5% | RF ablation can be considered (class II/a) in symptomatic persistent AF following failure of one AAD | Older pts with dilated LA + structural HD have high recurrence/ progression rates – AAD postablation is frequently needed | Personalized informed consent: | Single procedural 12 months success: 50-60%, 5y Multiple procedures:70-75%